Top companies

ASIANPAINT - 2459.9 (0.53%) AXISBANK - 1160.3 (-0.9%) BAJAJFINSV - 2072.1 (-0.59%) BAJFINANCE - 1029 (0.34%) BHARTIARTL - 1929.1 (-0.5%) BPCL - 330.1 (-0.09%) COALINDIA - 393.4 (-0.17%) HDFCBANK - 948.6 (-0.9%) HEROMOTOCO - 5275 (-1.78%) HINDUNILVR - 2556.9 (1.38%) ICICIBANK - 1380.8 (-0.97%) INDUSINDBK - 741.6 (-1.81%) ITC - 401.3 (-0.47%) KOTAKBANK - 2031.8 (-0.78%) MARUTI - 16232 (0.84%) ONGC - 239 (0.99%) RELIANCE - 1385.8 (-0.29%) SBIN - 866.6 (-0.46%) TATAMOTORS - 683.05 (-2.61%) TATASTEEL - 172.94 (-0.2%) TCS - 3041.4 (-0.69%) TITAN - 3422.7 (-0.48%) WIPRO - 244.71 (-1.97%)
TRENDING #BANK NIFTY 149 #ADANIPORTS 86 #ZOMATO 72

Top stock picks today: Brokerage recommendations on Tata Steel, Godrej Agrovet and more

07 Jul , 2021   By : Kanchan Joshi


Top stock picks today: Brokerage recommendations on Tata Steel, Godrej Agrovet and more

Indian benchmark equity indices closed in red on Tuesday after touching record highs during day's trade. The Sensex reached a new high of 53129.37, before closing 0.04% lower on Tuesday. Meanwhile, the Nifty 50 crossed the 15,900-mark yet again only to close 0.10% lower.


Sensex, Nifty may open flat on Wednesday as indicated by the SGX Nifty.


Brokerage recommendations:


Tata Steel: Edelweiss Securities in a note on July 5 said that the brokerage expects better days ahead for Tata Steel owing to profitable domestic operations and sustained turnaround in TSE in FY22. ‘’We expect TSE’s performance to get a leg up from contracts,’’ it said.


The brokerage has a ‘Buy’ stance on the stock with the target price of Rs1,300 apiece.


Godrej Agrovet: Brokerage firm Motilal Oswal Financial Services expects 76% sales and 85?itda (earnings before interest, taxes, depreciation, and amortization) on compounded annual growth rate (CAGR) basis for the palm oil segment over FY21–23, 39% revenue CAGR over FY21–23.


It has a Buy rating on the stock with the target price of Rs758 per share.


Dr Reddy’s: Nomura Financial Advisory Services in a note on July 5 said that the annual filings further reiterate the strategic and operational transformation of Dr Reddy’s Laboratories (DRL_. If executed successfully, it could lead to stronger earnings growth and a higher valuation multiple, it added.


Nomura has a ‘Buy’ rating on the pharma stock with target price of Rs6,145 per share.


STFC: For Shriram Transport Finance Co. (STFC), Emkay Global Financial Services in a note said ‘’we are now incorporating the latest issuance (capital raising) into our estimates but are building in some stress on asset quality for FY22-23 due to recent lockdowns.’’


It has a ‘Buy’ stance on the stock with target price of Rs1,630 per share.


0 Comment


LEAVE A COMMENT


Growmudra © 2026 all right reserved

Partner With Us